FATEX | SCIRX | FATEX / SCIRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 22 years | - |
Gain YTD | -0.047 | 1.214 | -4% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.07B | 14.3B | 49% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 12.93 | 7.04 | 184% |
Returns for 3 years | 38.30 | 9.68 | 396% |
Returns for 5 years | 77.58 | 44.12 | 176% |
Returns for 10 years | 207.59 | 96.47 | 215% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CEFIX | 12.21 | 0.01 | +0.08% |
Calvert Emerging Markets Advancement I | |||
QQMNX | 20.40 | -0.07 | -0.34% |
Federated Hermes MDT Market Neutral IS | |||
RIRFX | 72.51 | -0.25 | -0.34% |
American Funds Capital Income Bldr R5 | |||
GVIRX | 17.38 | -0.22 | -1.25% |
Goldman Sachs US Eq Div and Premium Inv | |||
LRSYX | 20.36 | -0.62 | -2.96% |
Lord Abbett Small Cap Value I |